{"name":"TopAlliance Biosciences","slug":"topalliance-biosciences","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"TAB004","genericName":"TAB004","slug":"tab004","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"TAB004","genericName":"TAB004","slug":"tab004","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPVDIzZVQyZDNPNDFBUVZ0RW1ydHVvdko0NXhxQmFxbXgzMk1RcUtManZod2JOdkl3UkU2YjVWcGtLY1pCa0tVajFjRjAtWVg1bjVMZ0NRdC0zQVY5UVByblhLWDA1MC1GQW5HV0psWWF6LVp3b1NObjZmbVBneXFvU2ZJYWRsaTRGNkRvSnpVTU1oSzdWTnpSem1Xaw?oc=5","date":"2025-01-23","type":"pipeline","source":"PMLiVE","summary":"LEO pharma gains EU rights to Junshi Biosciences’ PD-1 inhibitor toripalimab - PMLiVE","headline":"LEO pharma gains EU rights to Junshi Biosciences’ PD-1 inhibitor toripalimab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxORXBrRUJiRnJwMl9xeXd1ZUpra1dYckh4ekx0M2UtZDhPQjZ2ZVJGb0NWWTV6SjFKN0RiMmJaMkpZMmQxX2FqVF9VNlNMaTR1ZHdFd282dEx4YklDcTVPWDBjV3RpXzhUbVN6VWxoMk41LVBVOVdwVWlNOE5US0poLVlxaw?oc=5","date":"2025-01-21","type":"deal","source":"Pharmaceutical Technology","summary":"Junshi to partner LEO Pharma for toripalimab distribution - Pharmaceutical Technology","headline":"Junshi to partner LEO Pharma for toripalimab distribution","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQQzhHNEE3ZDRNX3hSQVVyRE03ZnFWVVliZThOQ21zcThDZGdRY3BJaXpTNWdwb0JZbk5INzlsUmRtdTd1RDVIaDdnN2pDb1RTZWY4YmR1d3ZLbXpUTEx0anZJUjM4VkI1NTFDUnZOdFAzUkxTcUYwN19pMkhvampaYVF4MzRhWURzS3JXLXlveHBOSjFWblh5cVJMQWxtNGNISWkwU2VkYTNrUFJRakxTbHNMQXFTWjBNVEE?oc=5","date":"2025-01-21","type":"pipeline","source":"Fierce Pharma","summary":"Leo bags EU rights to Junshi's Loqtorzi, putting marketing muscle behind PD-1 launch - Fierce Pharma","headline":"Leo bags EU rights to Junshi's Loqtorzi, putting marketing muscle behind PD-1 launch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOc0hCd0F5Y2hIRmQ2aVBIdnd6QVBCY281eTRqVW9vaEJVSFI0R0h5VkoyUHdIa2FOOG1QcGRYSUo5bk1TRDJGbk5kcFVMb0g2SUVtM3Zad0p3ejVKaVJmVnpfT3FjOW1Ya0s4bXQ5R2ZHR1pfcUxtT3ppdzdpWGMxd2NDc29kaW93NHdmUVFLMjNIZEE?oc=5","date":"2025-01-21","type":"deal","source":"The Pharma Letter","summary":"Junshi partners with LEO Pharma for toripalimab in Europe - The Pharma Letter","headline":"Junshi partners with LEO Pharma for toripalimab in Europe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxQSGo5Q2pmXy1XS3NqWmVZZkhhejVDd1Q5VXFPc3AyR2xfTUVFM3BCcDNMTTlRTVNBV2dpUWNKclgwQk4tZGU5WEJ5WUVGb08xX2JKS2ZyeU16TE9IbzlBQUxpamxwMFVPTUpLMU5kSTBTX1ptTVVDSWVRb1pMVkVFLUFEbUNObEMycHh1RUdXd1hVTlBiT1ZQdGxhN2pyNnlpYy0yYk4tREx6Y1VVM1BFUGVGWl9MWU9tNmdkc3lnM3A3VGUyRGVoOFk1ZG0yaTltNzMxYVNILTd4Q2F6UDNWVkJrUG8tRGtFQmRCbWhKQ0ZPV2ZFRk1LSFVMWQ?oc=5","date":"2025-01-21","type":"regulatory","source":"BioPharma APAC","summary":"Junshi Biosciences Secures Australian Approval for Toripalimab, First Immuno-Oncology Treatment for Nasopharyngeal Carcinoma - BioPharma APAC","headline":"Junshi Biosciences Secures Australian Approval for Toripalimab, First Immuno-Oncology Treatment for Nasopharyngeal Carci","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE02b1p0OWlBdVVkdGd0MTR3VXpCNy1WTFZjUlhzaUxCeThXdlVQb24yMElxZGpZM1FiTm0ybGtWNkRxQ0d6U3FPN1lQdXRVV2ZxYTFJ?oc=5","date":"2025-01-20","type":"pipeline","source":"FirstWord Pharma","summary":"LEO Pharma to market Junshi's PD-1 inhibitor Loqtorzi in Europe - FirstWord Pharma","headline":"LEO Pharma to market Junshi's PD-1 inhibitor Loqtorzi in Europe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE16c1pjZ2VxbV92T2k4d0JMbTU0MjVSS3AwSEtpM2RIUTByOGFKWFFrVnFLcDNTOWtsb2ZFWWx2djhXdUJ1RGMxTzRzTHdKRnVDTWFib0ZnS1VacXFQYmtnTy13V2JhT01zeTdVQzdTVVJ3Zw?oc=5","date":"2021-10-14","type":"regulatory","source":"MedPage Today","summary":"Newly Approved EGFR Drug Yields Meaningful Benefit in Rare NSCLCs - MedPage Today","headline":"Newly Approved EGFR Drug Yields Meaningful Benefit in Rare NSCLCs","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1Mb0REVGt6WWJCTlRfRG5PNTZrSUZJVTZIU1NWOXdkSzNkend0elpjcVdkUGo1UmdLQTMyM2RzZ2dXOUUyRDNlUkNDZklWa1hlWXVWZmNLSUlva2xvdTFzckVNMmRmbllPOVJ1TlNaQWVmSW9zNlJNZQ?oc=5","date":"2020-11-10","type":"pipeline","source":"Fierce Pharma","summary":"10 biotechs to know in China - Fierce Pharma","headline":"10 biotechs to know in China","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}